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Background: Apoptosis caused by inadequate or inappropriate cell-matrix interactions is defined as anoikis.
Although transformed cells are known to be anoikis-resistant, the underlying mechanisms have not been well
understood. We investigated the mechanisms of anoikis resistance of tumor cells.
Results: We observed that cell aggregation in suspension promoted cell survival and proliferation. We
demonstrated a correlation between tumor cell aggregation in suspension and cell growth in soft agar. Analysis of
tyrosine kinase-mediated cell survival and growth signaling pathways revealed increased levels of tyrosine-
phosphorylation of PECAM-1 and Pyk2 in cell aggregates. We also showed that PECAM-1 and Pyk2 physically
interact with each other, and that PECAM-1 carrying a deletion of exons 11-16 could no longer bind to Pyk2.
Furthermore, RNA interference-mediated reduction of Pyk2 and PECAM-1 protein levels reduced cell aggregation
and inhibited the growth of tumor cells in soft agar.
Conclusions: The data demonstrated that Pyk2 and PECAM-1 were critical mediators of both anchorage-
independent growth and anoikis resistance in tumor cells.
Background
Cell-extracellular matrix (ECM) interactions are essen-
tial for survival and growth of normal epithelial cells. In
the absence of matrix attachment, these cells have been
shown to undergo anoikis, a form of apoptosis [1].
Anoikis is important in maintaining normal cell and tis-
sue homeostasis to ensure a dynamic balance of cell
proliferation, differentiation, and apoptosis [2]. Anoikis
resistance and anchorage-independence are hallmarks of
oncogenic transformation and appear to play an impor-
tant role in tumor progression and metastasis [3,4].
Previous studies have shown that tumor cells tend to
form aggregates in the absence of matrix attachment.
The size and number of aggregates have been found to
correlate with survival [5,6]. Tumor cells that formed
aggregates in suspension cultures were found to exhibit
significantly lower levels of apoptosis than single cells,
indicating an increased resistance to anoikis. Cell
aggregation has also been found to correlate with colony
formation in soft agar and tumorigenecity in vivo [5-8].
Micrometastases resulting from such tumor cell aggre-
gates are thought to survive within the circulation or
bone marrow as small multicellular clusters or spher-
oids, thereby effecting suppression of anoikis, which is a
key property of these cells [9]. In addition, previous
research demonstrated that tumor cells cultured in
three-dimensional (3-D) aggregates could be used to
explain possible mechanisms of drug resistance [10].
The basis of cell aggregation is not well described.
Studying the molecular mechanisms mediating cell
aggregation could be very important in understanding
tumor cell growth and proliferation.
Cell-ECM and cell-cell interactions are mediated by
three classes of cell adhesion molecules: cadherins,
integrins, and Ig-superfamily proteins. The cadherins are
cell-surface proteins that mediate homophilic and cal-
cium-dependent cell-cell adhesions, crucial for structural
organization and differentiation of cells [11-14]. Integ-
rins are heterodimeric, cation-dependent cell-membrane
adhesion molecules that mediate cell-cell and cell-ECM
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cell spreading, invasion, and survival.
PECAM-1/CD31 (platelet endothelial cell adhesion
molecule-1), expressed on the surface of platelets and
leukocytes and at the lateral junctions of endothelial
cells, has been implicated in various biological functions,
such as leukocyte transmigration, cell migration, angio-
genesis, cell signaling, and cell adhesion [17]. Recently,
PECAM-1 expression has been found on many tumor
cells, such as human brain gliomas, carcinoma of the
cervix, lung cancer, and breast cancer [18-26]. However,
the significance of PECAM-1 expression in these cells is
not fully understood. The relationship between lung-
cancer PECAM-1 expression and cell adhesion, prolif-
eration, and migration prompted speculation that this
protein may play a role in the formation of tumor cell
aggregates.
Pyk2 (Proline-rich tyrosine kinase 2) belongs to the
FAK (focal adhesion kinase) family. FAK is activated by
the ECM, and it functions in cell motility and adhesion-
dependent survival [27]. The molecular structure of
Pyk2, its expression pattern, its physical association with
paxillin and other cytoskeletal proteins, and its potential
roles in multiple signaling pathways suggest that it might
play a pivotal role in various cellular events. Pyk2 is
involved in several cellular functions, such as adhesion,
motility, cell proliferation, apoptosis, and the G1-to-S
phase transition of the cell cycle [28-31]. Pyk2 also plays
a role in the regulation of prostate cell proliferation and
its expression may represent a sensitive marker of differ-
entiation of prostate cells [32-34]. While most of these
data were obtained from non-transformed epithelial cells,
several studies on prostate cancer cells suggest the invol-
vement of Pyk2 activation in invasion processes [32,35].
Moreover, some reports have shown high levels of Pyk2
expression in certain cancer cells, such as breast cancer,
lung cancer, and hepatocellular carcinoma, suggesting
that it may play a role in cancer cell proliferation, migra-
tion, and invasion[36-38]. Therefore, we hypothesized
that Pyk2 may play an important role in mediating cell
aggregation. Although Pyk2 interacts with many of the
same proteins as FAK, the functions of these protein
interactions are poorly understood [36,39].
In this study, we investigated the relationship between
tumor cell aggregation and growth in suspension cul-
tures. We studied the function of cell aggregates and cell
aggregate-mediated signaling pathways. We demonstrated
that cell aggregation promotes tumor cell growth in sus-
pension. The ability of tumor cells to form aggregates in
polyHEMA suspension correlated with their ability to
grow in soft agar. We also report that the Pyk2/PECAM-
1 complex is a key signal transducer meditating cell
aggregation-generated survival and/or growth signals.
Methods
Cell culture
Kidney epithelial cells (MDCK), human lung adenocarci-
noma cells (NCI-H1792), human non-small cell lung
cancer cells (SK-LU-1), human lung adenocarcinoma
cells (A549), and large cell human lung carcinoma cells
(NCI-H460) were obtained from American Type Cell
Culture Collection (ATCC, Rockville, MD). The cells
were cultured in Dulbecco’s Modified Eagle Medium
(DMEM) supplemented with 10% fetal calf serum (FCS),
100 IU·ml
-1 streptomycin, and 100 μg·ml
-1 penicillin.
HBE4-E6/E7 (human papillomavirus 16E6/E7 trans-
formed normal lung bronchus epithelial cells), obtained
from ATCC, were cultured in Keratinocyte Serum-Free
Medium (GIBCO, USA) with 0.05 mg·ml
-1 bovine pitui-
tary extract, 5 ng·ml
-1 recombinant human epithelial
growth factor, and 10 ng·ml
-1 cholera toxin.
Soft agar assay
Cells were suspended in 0.3% agar medium (DMEM
containing 10% FBS) and then plated on a 0.6% agar
base layer at a concentration of 4 × 10
4 cells per 60-mm
dish. The cells were incubated in a humidified atmo-
sphere (5% CO2) at 37°C. The number of colonies that
were 50 μm or larger were counted after two weeks.
Cell aggregation assay
Cells were grown to 70% confluence and then trypsi-
nized. They were then seeded in 60-mm polyHEMA-
coated petri dishes at different densities and incubated
for different periods of time. The cells were subsequently
examined under an inverted phase-contrast microscope,
photographed, and counted. The polyHEMA-coated
dishes were prepared by coating the plates twice with 2
ml polyHEMA solution [10 mg/ml polyhydroxyethyl-
methacrylate (Aldrich Chemical Co., Milwaukee, WI) in
ethanol] and were dried in a tissue culture hood for 24 h.
They were then washed twice with PBS before use.
DNA extraction and electrophoresis
Cells were lysed in DNA lysis buffer containing 0.5% Tri-
ton X-100, 10 mM EDTA (pH 8.0) and 10 mM Tris
(pH7.6). The cell lysates were kept on ice for 1 h and then
extracted twice with an equal volume of chloroform/phe-
nol, followed by one extraction with chloroform. DNA
was precipitated, washed with 70% ethanol, air-dried at
room temperature, and resuspended in TE buffer (10 mM
Tris·Cl, 1 mM EDTA, pH 7.5). DNA was resolved by elec-
trophoresis in 2% agarose and photographed.
Flow cytometry analysis
Apoptosis was measured with the Annexin V-FITC
Apoptosis Detection KIT (CALBIOCHEM) and analyzed
by flow cytometry (FACScan; Becton Dickinson).
Immunoprecipitation analysis
Cells were washed with PBS and lysed in Triton lysis buf-
fer (2% Triton X-100, 10 mM EGTA, 15 mM HEPES,
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fonyl fluoride, 10 mg·ml
-1 aprotinin, 10 mg·ml
-1 leupep-
tin, and 2 mM sodium orthovanadate, pH 7.4) at 4°C for
30 min. Triton-soluble and -insoluble fractions were
separated by centrifugation at 15,000 × g for 5 min at 4°
C. The supernatant was precleared by incubating with 40
μl of protein A-agarose beads for 30 min at 4°C and then
centrifuged. Precleared lysates were incubated overnight
with PECAM-1 or Pyk2 antibody, and the immune com-
plexes were recovered by incubating with 40 μlo fp r o -
tein-A agarose beads and centrifuging. The
immunoprecipitates were washed three times with the
Triton lysis buffer and then resolved by 7.5% SDS-PAGE.
RNAi plasmid construction
pRETRO-SUPER RNA interference constructs were cre-
ated as described previously[ 4 0 ] .T h eo l i g onucleotide
sense strand for PYK2 was 5’-gatccccCTGGTCAAATG-
CACTGTCCttcaagagaGGACAGTGCATTTGACCAG
tttttggaaa3’, and for PECAM was 5’-gatcccc ACCACTG-
CAGAGTACCAGCttcaagagaGCTGGTACTCTGCAG
TGGT tttttggaaa3’. The 19-nt target sequences are indi-
cated in capital letters.
Cell transfection and retroviral infection
Ecotropic retroviral supernatants were produced by
transfection of packaging cells using calcium-phosphate
precipitation method. At 48 h post-transfection, the cell
culture medium was filtered through a 0.45 μmf i l t e r ,4
μg/ml polybrene was added, and the virus-containing
supernatant was used to infect H460 cells. After 6 h of
infection, cells were allowed to recover for 24 h in fresh
medium. Infected cells were selected with puromycin (2
μg/ml) (Invitrogen, Carlsbad, CA) for 48 h.
Co-immunoprecipitation of PECAM and Pyk2 in 293T cells
293T cells (1 × 10
6) were transfected with pcDNA 3.1
empty vector, PECAM FL construct, PECAM Mu (Δ11-
16) construct, PYK2 construct, or a combination of
these using Lipofectamine Reagent (Invitrogen, Carlsbad,
California). The pcDNA/Pyk2 construct was a kind gift
from Dr. Mike Schaller (UNC-Chapel Hill). The full-
length PECAM-1 and Δ11-16 PECAM-1 (exons 11-16
deleted) constructs were a kind gift from Dr. Steven M.
Albelda (Univ. Pennsylvania). After 48 h, cell lysates
were prepared in lysis buffer (100 mM Tris, pH 8.0, 100
mM NaCl, 0.5% Nonidet P-40, 1 mM phenylmethylsul-
fonyl fluoride) and precleared with protein A-Sepharose
beads (Amersham Biosciences). Protein lysates (1-mg
aliquots) were immunoprecipitated with anti-PECAM-1
antibody (Santa Cruz Biotechnology, Santa Cruz, CA) or
anti-Pyk2 antibody (Biosource), followed by immuno-
blotting with an anti-Pyk2 antibody and anti-PECAM-1
antibody. Immunoreactivity was detected using the
Enhanced Chemiluminescence system (ECL, Amersham
Pharmacia Biotech, Piscataway. NJ).
Immunoblotting
Cells were washed with PBS and resuspended in lysis
buffer (50 mM Tris PH 7.5, 150 mM NaCl, 1%NP40,
0.1%SDS, 1 mM PMSF, 1 mM orthovanadate, 1 mM
Na4P2O7,10 mg·ml
-1 aprotinin, and 10 mg·ml
-1 leupep-
tin ) at 4°C for 30 min and centrifuged (13,000 × g,5
min at 4°C). Protein concentrations of the lysates were
determined using the Bio-Rad protein assay kit (Bio-Rad
Laboratories, CA ). Protein (30 μg) was resolved on
SDS-PAGE and transferred onto a nitrocellulose filter.
Blocking was carried out for 1 h at room temperature in
5% nonfat milk made in TBS containing 0.05% Tween
20 (TBST). The membrane was then incubated over-
night at 4°C in primary antibody (1:1000 dilution) fol-
lowed by a 1-h incubation with horseradish peroxidase-
conjugated goat anti-mouse or anti-rabbit IgG secondary
antibody (1:2000 dilution). The 4G10 (anti-phosphotyro-
sine) antibody was purchased from Millipore, anti-phos-
phorylated-Pyk2 (pY-881) was purchased from
Biosource (Invitrogen), and anti-cleaved caspase-3
(Asp175) antibody was purchased from Cell Signaling.
Immunoreactivity was detected using the Enhanced
Chemiluminescence system (Amersham).
Results
Cell aggregation induces survival and growth signals
We used several cell culture-based approaches to study
the molecular mechanism of tumor cell anoikis resis-
tance, or anchorage-independent survival. Our first
strategy was to culture cells in polyHEMA-coated
dishes, which prevents cells from attaching to the cul-
ture dish and forces the cells to grow in suspension
[41,42]. We observed that these tumor cells often
formed cell aggregates, and the size and tightness of the
aggregates varied depending on the cell line used (Fig.
1A upper). The H1792 and H460 cells formed large and
compact aggregates, while the SK-LU-1 and A549 cells
formed small and loose aggregates. Most of the MDCK
and HBE cells, the non-tumor cell lines, did not form
aggregates (Fig. 1A upper).
We analyzed the survival and growth of all of our cell
lines in suspension and in soft agar to determine
whether cell aggregation played a role in their survival
and growth. We found that cell aggregation correlated
with soft agar growth (Fig. 1A and 1B) (r = 0.999, P <
0.001). Normal MDCK and HBE cells, which did not
form aggregates, failed to form colonies in soft agar.
The SK-LU-1 cells, which did not form large aggregates
in polyHEMA suspension, and the A549 cells, which
formed loose aggregates, grew more slowly in soft agar
than the H1792 and H460 cells, which formed large,
tight aggregates and grew faster in soft agar (Fig. 1A
upper and lower). In suspension culture we also found
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Page 3 of 11Figure 1 C e l la g g r e g a t i o nc o r r e l a t e dw i t hc e l lg r o w t hi ns u s p e n s i o nc u l t u r ea n di ns o f ta g a r . A, Upper panel: Cell aggregation in
polyHEMA-coated dishes (× 100). H1792, H460, A549, SK-LU-1, MDCK, and HBE cells were cultured on 60-mm polyHEMA-coated dishes (2.5 ×
10
5/dish) for 8 hours and photographed. Lower panel: Colony-formation of cells in soft agar. 4 × 10
4 cells were seeded into 60 mm soft agar
plates and incubated for 2 weeks and photographed. B, Correlation between cell aggregation and soft agar growth. The numbers of clonies
formed in soft agar after 14 d incubation were plotted against the mean numbers of cell aggregates per 10 fields formed in polyHEMA-coated
dishes. Pearson’s correlation coefficient was used. N: Number C, Proliferation of tumor cells and normal cells in regular (left) and polyHEMA-
coated (right) dishes. Cells as indicated from regular cell culture dishes were plated into regular or polyHEMA-coated dishes (4 × 10
4/dish) for 1,
2, 3, 4 or 5 d. At the end of each incubation viable cells were counted using trypan blue exclusion. D, Cell aggregation promoted tumor cell
proliferation in suspension cultures. 2.5 × 10
4 tumor cells as indicated from regular cell culture dishes were plated into polyHEMA-coated or
methyl cellulose plates for 1, 2, or 3 d. At the end of each incubation viable cells were counted using trypan blue exclusion. Data from at least
three separate experiments were analyzed using Student’s t test. “***": P < 0.001. S: Suspension culture in polyHEMA-coated dishes MS:
Suspension culture in methyl cellulose dishes.
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H460 and H1792 cells, grew faster than those cells that
formed small aggregates, such as SK-LU-1 and A549
cells (Fig. 1C). These results clearly demonstrate that
the ability of the tumor cells to form aggregates in poly-
HEMA suspension not only correlates with the tumor
cell growth in polyHEMA suspension but also correlates
with their ability to grow in soft agar.
In order to further examine the role of cell aggrega-
tion in cell growth, we used methyl cellulose in the cul-
ture medium to decrease cell aggregation in suspension.
The size of cell aggregates in the H1792 and H460
decreased in the methyl cellulose suspension (MS) cul-
tures compared with that in the polyHEMA suspension
(S) cultures. We observed decreased cell growth in the
H1792 and H460 cells in methyl cellulose cultures com-
pared to polyHEMA suspension cultures (Fig. 1D).
These data suggest that cell aggregation provides growth
signals to tumor cells in suspension.
However, we did not observe a correlation between
cell aggregation and survival in the case of tumor cells
in suspension. The H460 tumor cells, which formed
large and tight aggregates in suspension, underwent par-
tial anoikis in suspension (Fig. 2A-C). On the other
hand, the SK-LU-1 tumor cells, which did not form
large aggregates and grew slowly in suspension (Fig.
1C), were completely resistant to anoikis (Fig. 2A).
While aggregation of H460 cells provided adequate sig-
nals for cell growth (Fig. 1C), it was not sufficient to
protect the cells from undergoing anoikis (Fig. 2A).
These data suggest that the signals for tumor cell
anchorage-independent survival and growth were
distinct.
Cell aggregation induces tyrosine phosphorylation of
PECAM-1 and Pyk2
In order to understand the molecular nature of the cell
aggregation-generated survival and growth signals, we
analyzed the phosphorylation/activation of PECAM-1
and Pyk2. PECAM protein was immunoprecipitated
with PECAM antibody and then immunoblotted with
4G10 antibody (anti-phosphotyrosine monoclonal anti-
body) to detect tyrosine phosphorylation. Interestingly,
we found that the phosphorylation/activation of
PECAM-1 and Pyk2 correlated with cell aggregation,
although the total protein level of PECAM-1 and Pyk2
were not related to cell aggregation (Fig. 3A, B and
Additional file 1 Figure S1). High- and low-density sus-
pension cultures were established in order to study the
phosphorylation status of these molecules in relation to
cell aggregation. H460, SK-LU-1, and HBE cells formed
larger aggregates in high-density cultures compared to
low-density cultures. H460 and H1792 formed larger
aggregates in polyHEMA cultures compared to methyl
cellulose cultures. We observed higher levels of
phosphorylated PECAM-1 and Pyk2 in large aggregates
(high-density cultures, H) than in small aggregates or
single cells (low-density cultures, L) (Fig. 3A)Similarly,
higher levels of phosphorylated PECAM-1 and Pyk2
were seen when cells were cultured in large aggregates
(polyHEMA suspension culture, S) compared to small
aggregates (methyl cellulose suspension culture, MS)
(Fig. 3B), suggesting that the phosphorylation/activation
of PECAM-1 and Pyk2 correlated with cell aggregation.
PECAM-1 and Pyk2 knock-down reduce aggregation-
mediated cell growth
The above experiments suggested that the phosphoryla-
tion/activatio of PECAM-1 and Pyk2 correlated with cell
aggregation. In order to investigate the role of PECAM-
1 and Pyk2 in the formation of cell aggregates, we used
RNA-interference (RNAi) technology to knock down the
e x p r e s s i o no fP E C A M - 1o rP y k 2i nN C I - H 4 6 0a n d
A549 cells. We found significantly decreased expression
levels of the target proteins in the RNAi-infected cells
(Fig. 4A).
Cells with knock-down of Pyk2 or PECAM-1 expres-
sion showed a decrease in the size and tightness of cell
aggregates (Fig. 4B) along with a decreased ability to
grow in soft agar (Fig. 4C). PECAM or Pyk2 knock-
down cells also formed only about 30% to 50% the num-
ber of colonies in soft agar as the control cells (Fig. 4D).
Taken together, these data demonstrate that the expres-
sion of Pyk2 and PECAM is important in the formation
of tumor cell aggregates and could promote the ancho-
rage-independent growth of H460 and A549 cells in soft
agar.
PECAM-1 physically interacted with Pyk2
Since both Pyk2 and PECAM-1 are important in med-
iating the formation of tumor cell aggregates and pro-
moting the anchorage-independent growth, we used co-
immunoprecipitation to investigate possible interactions
between PECAM-1 and Pyk2. We found that PECAM-1
and Pyk2 co-immunoprecipitated in H460 and A549
cells, suggesting an endogenous interaction between
these two molecules in these cells (Fig. 5A and 5B).
To further confirm the interaction between Pyk2 and
PECAM-1, we co-transfected 293T cells with an expres-
sion vector for Pyk2, along with an expression vector for
full-length PECAM-1 or PECAM-1 carrying an exon 11-
16 deletion. We demonstrated that Pyk2 was co-immu-
noprecipitated with the full-length version, but not the
deletion mutant, of PECAM-1 (Fig. 5C) clearly demon-
strating a direct physical interaction between PECAM-1
and Pyk2.
Discussion
We found that tumor cells formed different sizes of
aggregates in suspension cultures and that tumor cells
grew slowly when their cell-cell interactions were
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Page 5 of 11Figure 2 Detachment from ECM induced apoptosis in normal epithelial MDCK and HBE cells. A, DNA laddering analysis of cell death.
Normal cells and tumor cells from regular cell culture dishes (1 × 10
7 ) were plated into 100-mm polyHEMA-coated dishes for 24 h and harvested.
Cytosolic DNA was extracted and analyzed by agarose gel electrophoresis. B and C Annexin V staining analysis of cell death. 5 × 10
5 MDCK, HBE,
and H460 cells from regular cell culture dishes were plated into 60-mm polyHEMA-coated dishes for 24 h, harvested, fixed, and assessed by
Annexin V/propidium iodide (AV/PI) DNA staining and flow cytometry. B, Percent of early apoptotic cells determined by flow cytometry using AV/PI
binding. Quadrant D1: PI/AV +/-, necrotic; D2: PI/AV +/+, late apoptotic/necrotic; D3: PI/AV -/-, live cells; D4: PI/AV -/+, early apoptotic cells. C,
Histograms of flow cytometry data. Data from at least three separate experiments were analyzed using Student’s t test. “***": P < 0.001. A: Attached
culture; S: Suspension culture in polyHEMA-coated dishes. D, Immunoblotting analysis of cleaved caspase-3. After the indicated time periods cells
were lysed and total protein was extracted separated by SDS-PAGE, and analyzed by immunoblotting with the indicated antibodies. Tubulin was
used as a loading control. A: Attached culture; S: Suspension culture in polyHEMA-coated dishes. “***": P < 0.001.
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polyHEMA suspension correlated with their ability to
grow in soft agar. Furthermore, the aggregated cells had
higher levels of phosphorylated PECAM-1 and Pyk2 than
single cells. Inhibition of PECAM-1 or Pyk2 expression
using RNA interference impaired cell aggregation and
decreased colony-forming ability. We were also able to
demonstrate that PECAM-1 and Pyk2 physically inter-
acted with each other. These observations led us to con-
clude that cell aggregation induced phosphorylation of
PECAM-1 and Pyk2 and that the two molecules were key
signaling mediators to promote anchorage-independent
survival and growth of tumor cells.
Our findings that the ability of tumor cells to form
aggregates in polyHEMA suspension correlates with
their ability to grow in soft agar are consistent with
previous reports. Transformed rat, mouse, hamster, and
human cells were found to form aggregates twice as
large as those formed by non-transformed cells. The
same results have been reported in chemical-trans-
formed rat liver cells and virus-transformed rat and
hamster embryo cells [5,43]. Differences in size of cell
aggregates have been proposed as novel indicators of
malignant transformation [8,44].
We found that the interactions of cell aggregates contri-
bute to inhibition of cell death or anoikis-resistance.
While normal cells die upon losing their cell-cell interac-
tions, tumor cells escape anoikis because they either obtain
survival signals from increased cell aggregation or acquire
bypass mutations [3]. We showed that tumor cells forming
large aggregates proliferated faster than tumor cells form-
ing small aggregates. Aggregated cells adhered to one
Figure 3 Induction of phosphorylation of Pyk2 and PECAM by cell aggregation. A, Phosphorylation of Pyk2 and PECAM in high versus low
cell density cultures. Different concentrations of HBE, SK-LU-1, or H460 cells (H: 5.0 × 10
5 cells L: 2.5 × 10
5 cells) were cultured in 60-mm
polyHEMA-coated dishes for 0, 6, or 15 h. Cell lysates were resolved by SDS-PAGE and analyzed by immunoblotting with anti-phospho-Pyk2
(Tyr881), or anti-Pyk2 antibody (left). Equal amounts of whole-cell extracts were immunoprecipitated with anti-PECAM antibody followed by
immunoblotting with 4G10 antibody (Right). B. Phosphorylation of Pyk2 and PECAM in regular suspension versus methyl-cellulose suspension
cultures. H1792 and H460 cells were cultured in polyHEMA-coated dishes (S) or methyl-cellulose dishes (MS) for 6 or 15 h, harvested, and lysed
with RIPA buffer. A, Equal amounts of whole-cell extracts were immunoprecipitated with anti-PECAM antibody followed by immunoblotting with
anti-phosphotyrosine 4G10 antibody (Upper). Equal amounts of whole-cell extracts were immunoblotted with anti-pPyk2 (Tyr881) or anti-Pyk2
antibody (Lower).
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tum, and tolerated the three-dimensional stress that affects
cell shape, membrane signal transduction, and prolifera-
tion. We propose that this could be why cell aggregation
promotes cell proliferation. Cell-cell homophilic adhesion
or aggregation is also important in tumor cell invasiveness
and metastasis [6,9,10,45]. Therefore, identification of key
molecules that mediate the cell aggregation-generated cell
survival and proliferation signals are important for devel-
oping new strategies to treat cancer.
It is known that the cadherin receptor family, integrin
receptor family, and activation of EGFR all play a role in
promoting anchorage-independent survival and spread of
tumor cells. Several studies have shown that cadherins
are important for survival signaling, in addition to pro-
viding anchorage between neighboring cells [9,46-48].
Recent studies show that FAK (focal adhesion kinase),
along with integrin a5b1 (which binds fibronectin), med-
iates the signaling pathway that results in anchorage of
cells to ECM [49,50]. EGFR is important in the survival
of colorectal carcinoma cells and confers resistance to
anoikis in suspension cultures of normal epidermal kera-
tinocytes and mammary epithelial cells [45,51]. Our data
demonstrate that PECAM-1 and Pyk2 are also critical
molecules in supporting tumor cell anchorage-indepen-
dent growth. Future studies are needed to understand the
relationship of these molecules.
We found that the phosphorylation of Pyk2 (Y881) cor-
related with aggregate-dependent cell growth. To our
knowledge, we are the first to report a relationship
between activated Pyk2 and anchorage-independent
growth. Recent reports show that Pyk2 is overexpressed
in certain cancer cells, including non-small cell lung can-
cer, and higher Pyk2 activity is correlated with enhanced
cell migration in A549 cells [52,53]. Overexpression of
Pyk2 in human HCC cell lines also results in enhanced
colony formation and promotes cell proliferation and
invasiveness [54]. These data support our finding that
activation of Pyk2 promoted formation of cell aggregates
and cell proliferation in soft agar, which suggests a possi-
ble role of Pyk2 in tumor progression and metastasis.
It is known that phosphorylation of Pyk2 leads to the
recruitment of Src-family kinases and the activation of
ERKs [54]. However, we found that Pyk2 tyrosine phos-
phorylation is dissociated from the activation of the
MAPK pathway in these aggregation experiments (Addi-
tional file 2 Figure S2), suggesting that Pyk2 is involved
in other cellular signaling pathways. We previously
showed that detachment-induced Src activation in
tumor cells contributed to their anoikis resistance. Pyk2,
rather than PI3K/Akt or Erk, appears to be the key
downstream effecter of Src in mediating the cell survival
signals in cell aggregates [55,56]. In future studies, it
would be important to investigate the role of the inter-
action between Src and Pyk2 in tumor cell aggregation.
PECAM-1 has been reported to be expressed in cer-
tain carcinoma cells and contributes to tumor cell adhe-
sion [26]. PECAM-1 surface expression plays a role in
cancer cell growth and metastasis [57,58]. Interestingly,
we found that the phosphorylation of PECAM-1 corre-
lated with aggregate-dependent growth and cell adhe-
sion. Furthermore, knockdown of PECAM-1 expression
decreased the size of tumor cell aggregates and their
colony-forming ability. These data strongly suggest that
Figure 4 Knock-down of PECAM-1 or Pyk2 decreased cell
aggregation and colony formation in soft agar. A, H460 (left)
and A549 (right) cells were infected with pRetrosuper/Pyk2,
pRetrosuper/PECAM-1, or scrambled (negative control) RNAi
retrovirus. The cells were then selected with puromycin for 48 h.
RNAi-infected cell lysates were analyzed for the level of protein
expression by immunoblotting analysis using the antibodies
indicated. Anti-tubulin antibody was used to show equal protein
loading. B, The morphology of aggregates of H460 cells (left) and
A549 (right) infected with PECAM or Pyk2 RNAi vectors. The RNAi-
infected cells were selected with puromycin for 48 h. Cells were
harvested cultured on 100-mm polyHEMA-coated dishes for 8 h,
and photographed by phase-contrast microscope (× 40). C and D
Function of PECAM-1 or Pyk2 in promoting soft agar growth of
H460 (left) and A549 (right) cells. C. RNAi-infected cells were
harvested and plated in soft agar grown for 2 wk at 37°C, and
assayed for colony formation. D, Graphical representation of
microscopy data expressed as the percentage of colonies. Data
from at least three separate experiments were analyzed using
Student’s t test. “***": P < 0.001
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leading to cell aggregation and growth in suspension.
More interestingly, we found that Pyk2 and PECAM-1
physically interact with each other. This is the first
report of an interaction between PECAM-1 and Pyk2.
This finding suggests a novel signaling complex that is
responsible for cell aggregation and tumor cell ancho-
rage-independent growth. Our future work will investi-
gate the downstream signaling pathways mediated by
this interaction.
Conclusions
Signals generated by cell aggregation are different from
cell-matrix interactions. Cell-ECM interactions are
mediated mainly by integrin and FAK signals and con-
tribute to cell survival. Tumor cell aggregate formation
is mediated by PECAM-1 and Pyk2 signal transduction,
leading to cell proliferation. We have identified a novel
physical interaction between PECAM-1 and Pyk2, which
could play an important role in tumor cell aggregate
formation in suspension cultures and in aggregate-
dependent proliferation. Our results could be important
in providing new insights into the mechanisms of anoi-
kis resistance, tumor progression, and tumor metastasis.
It may also provide a new class of targets for the devel-
opment of new therapeutics in cancer treatment.
Additional file 1: Expression of Pyk2 and PECAM in non-cancerous
and cancer cells. HBE, MDCK, SK-LU-1, A549, H1792 or H460 cells were
cultured on 60-mm regular and polyHEMA-coated dishes for 15 h. Cell
lysates were resolved by SDS-PAGE and analyzed by immunoblotting
with anti Pyk 2, anti-PECAM, or anti-tubulin antibodies as indicated.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1476-4598-9-7-
S1.pdf]
Figure 5 PECAM-1 interacted with Pyk2 physically in vivo. A and B Binding of endogenous PECAM with endogenous Pyk2 in H460 (A) and
A549 (B) cells. Confluent H460 and A549 cells from regular cell culture dishes were plated onto 100-mm polyHEMA-coated dishes for 3 or 15 h.
Cells were harvested and lysed. Equal amounts of whole-cell extracts were immunoprecipitated with anti-PECAM-1 antibody, anti-Pyk2 antibody,
or anti-Flag antibody followed by immunoblotting with anti-Pyk2 antibody or anti-PECAM-1 antibody. C, In vivo interaction of Pyk2 and PECAM-1
in 293T cells. 293T cells (1 × 10
6/100-mm dish) were co-transfected with pCDNA3.1 empty vector, PECAM FL construct, PECAM Mu (Δ11-16)
construct, PYK2 construct, or a combination as indicated. After treatment for 48 h, equal amounts of whole-cell extracts were
immunoprecipitated with anti-PECAM antibody and immunoblotted for Pyk2 and PECAM (upper) or immunoprecipitated with anti-Pyk2 antibody
and immunoblotted for PECAM and Pyk2 (middle). Western blot analysis of equal amounts of cell extracts was also performed in parallel (lower).
FL: Full-length; Mu: Mutant (Δ11-16).
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Page 9 of 11Additional file 2: Phosphorylated level of ERK MAPK in non-
cancerous and cancer cells. HBE, A 549 and H460 cells were cultured
on regular and polyHEMA-coated dishes for 15 h. Cell lysates were
resolved by SDS-PAGE and analyzed by immunoblotting with anti-
phospho-p44/42 ERK MAPK, anti-ERK MAPK or anti-tubulin antibodies as
indicated.
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